In January 2024, EYLEA 8mg achieved new heights in Bayer’s mission of 'helping patients see a better life'. You celebrated this major milestone in the EYLEA journey by attending the EYLEA 8mg Global Townhall on January 16, 2024. Either in person in Basel or virtually worldwide. You met the hosts Jan Voss and Zoran Hasanbasic (EYLEA IPT Leads) and the full cross-functional team and learned what they achieved to bring EYLEA 8mg to market, also what the real benefit means to patients and their caregivers. Anne-Grethe Mortensen, Mike Devoy and Stefan Oelrich brought their perspectives and spoke about what this success-story meant to the Pharma division and to the company as a whole. https://www.bayer.com/poap